Work

Reducing delays to neoadjuvant chemotherapy in triple negative or Her2+ breast cancer.

Year: 2025

Type: conference-abstract

Source: JCO Oncology Practice

DOI: 10.1200/op.2025.21.10_suppl.473

Authors: Bryn Thompson, Lisa Hamilton, Kate Then, Alicea Anderson, Ashraf Mohamed, Kathlene DeGregory, Sara Rebecca Torgerson

Institutions: Minnesota Oncology, Saint Francis Hospital, Saint Francis Health System, University of Virginia

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414893192

Cites:

Cited by:

Related to: